The New Mass Torts Bargain

50 Pages Posted: 12 Aug 2020 Last revised: 25 Oct 2021

See all articles by Samir D. Parikh

Samir D. Parikh

Lewis & Clark Law School; Fulbright Schuman Scholar; Bloomberg Law; Fulbright Commission

Date Written: July 12, 2020

Abstract

Mass torts create a unique scale of harm and liabilities. Corporate tortfeasors are desperate to settle claims but condition settlement upon resolution of substantially all claims at a known price – commonly referred to as a global settlement. Without this, corporate tortfeasors are willing to continue with protracted and fragmented litigation across jurisdictions. Global settlements can be elusive in these cases. Mass torts are oftentimes characterized by non-homogenous victim groups that include both current victims and unknown, future victims – individuals whose harm has not yet manifested and may not do so for years. Despite this incongruence, the claims of these future victims must be aggregated as part of any global settlement. This is the tragedy of the mass tort anticommons: without unanimity, victim groups are unable to access settlement resources in a timely or meaningful way, but actual coordination across the group can be impossible.

Current resolution structures have proven ill-equipped to efficiently and equitably address the novel challenges posed by mass torts. Many cases cannot satisfy Rule 23’s requirements for class action certification. Multidistrict litigation is the most frequently invoked resolution structure, but the MDL process is distorted. The process was initially designed for one district court to streamline pretrial procedures before remanding cases for adjudication. Instead, MDL courts have turned into captive settlement negotiations. In response, a new strategy for resolving modern mass torts has emerged. Corporate tortfeasors – including Purdue Pharma, Boy Scouts of America, and USA Gymnastics – have started filing for bankruptcy. These mass restructurings automatically halt the affected MDL cases and transfer proceedings to a bankruptcy court – a process I describe as bankruptcy preemption. Unfortunately, bankruptcy preemption replaces one deficient structure with another. Mass restructuring debtors are exploiting statutory gaps in the Bankruptcy Code in order to bind victims through an unpredictable, ad hoc structure. The new bargain creates myriad risks, including insolvent settlement trusts and disparate treatment across victim classes.

This Article is the first to attempt a reconceptualization of how modern mass torts should be resolved and delivers an unprecedented normative construct focused on addressing anticommons dynamics through statutory amendments to the Bankruptcy Code. These changes, coupled with an evolved perspective on fundamental structural anomalies, are designed to improve predictability, efficiency, and victim recoveries. More broadly, this Article attempts to animate scholarly debate of this new, non-class aggregate litigation strategy that will reshape the field.


Keywords: mass torts, multidistrict litigation, class actions, bankruptcy, civil procedure, torts, corporate restructurings, Purdue Pharma, Takata, Boy Scouts of America, USA Gymnastics, Imerys

JEL Classification: K13

Suggested Citation

Parikh, Samir D., The New Mass Torts Bargain (July 12, 2020). Fordham Law Review, Forthcoming 2022, Available at SSRN: https://ssrn.com/abstract=3649611 or http://dx.doi.org/10.2139/ssrn.3649611

Samir D. Parikh (Contact Author)

Lewis & Clark Law School ( email )

10015 S.W. Terwilliger Blvd.
Portland, OR 97219
United States

Fulbright Schuman Scholar ( email )

United States

Bloomberg Law ( email )

New York
New York, NY
United States

Fulbright Commission ( email )

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
335
Abstract Views
1,047
rank
114,015
PlumX Metrics